Chase Investment Counsel’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
Chase Investment Counsel's AGN Position: Q2 2020 in Review
Chase Investment Counsel sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 6,750 shares — an estimated $1.2M sold.
Chase Investment Counsel first reported a position in AGN in Q2 2013 and held it in 11 quarters. The position peaked at $11.3M in Q2 2013. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Chase Investment Counsel reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- Chase Investment Counsel sold 6,750 Allergan plc shares in Q2 2020, an estimated $1.2M.
- Chase Investment Counsel first reported a position in Allergan plc in Q2 2013 and held it in 11 quarters.
- Chase Investment Counsel's Allergan plc position peaked at $11.3M in Q2 2013.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Chase Investment Counsel's 13F filing for Q2 2020, filed 5 Aug 2020.